ehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus. His cardiovascular risk was > 15% http://www.cvdcheck.org.au/ His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol. http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs. Management of his condition now includes the following: Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013). Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis Medications: Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food ramipril 5 mg, daily Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily Ongoing diagnostics: HbA1c: every 3 months
ehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus. His cardiovascular risk was > 15% http://www.cvdcheck.org.au/ His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol. http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs. Management of his condition now includes the following: Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013). Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis Medications: Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food ramipril 5 mg, daily Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily Ongoing diagnostics: HbA1c: every 3 months
Chapter13: Dimensional Analysis/units Conversion
Section: Chapter Questions
Problem 1SST
Related questions
Question
Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.
His cardiovascular risk was > 15% http://www.cvdcheck.org.au/
His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol.
http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx
He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs.
Management of his condition now includes the following:
- Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
- Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
- Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
- Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis
Medications:
- Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
- ramipril 5 mg, daily
- Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily
Ongoing diagnostics:
- HbA1c: every 3 months
- lipid profile: every 3 months
- renal function assessment: annually
- podiatrist assessment: at least once a year
- optometrist assessment: at least once a year
question:
relate metformin therapy to Mehmet's pathophysiological presentation in brief.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps
Follow-up Questions
Read through expert solutions to related follow-up questions below.
Follow-up Question
- From this list choose TWO (2)therapies to discuss:
- empagliflozin
- metformin
- rosuvastatin
- ramipril
You need to do the following for each medication:
- describe the mechanism of ACTION/S
- identify the AIM of each therapy for Mehmet
- relate each therapy to Mehmet's pathophysiological presentation
- refer briefly to any GUIDELINES which support the use of each medication
- identify one RISK or special consideration for Mehmet whilst taking each medication
- identify what evidence will demonstrate the EFFECTIVENESS of each therapy if you were evaluating care provided to Mehmet
Solution
by Bartleby ExpertRecommended textbooks for you